Teleflex Incorporated (NYSE:TFX) to Issue $0.34 Quarterly Dividend

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Thursday, August 6th. Investors of record on Friday, August 14th will be given a dividend of 0.34 per share by the medical technology company on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th.

Teleflex has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $10.55 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.9%.

Teleflex Trading Up 2.1%

Shares of TFX traded up $2.83 during mid-day trading on Thursday, reaching $139.61. The company had a trading volume of 1,301,231 shares, compared to its average volume of 800,740. The stock has a market cap of $6.18 billion, a price-to-earnings ratio of -6.12, a price-to-earnings-growth ratio of 1.04 and a beta of 0.81. The firm has a fifty day simple moving average of $131.41 and a 200-day simple moving average of $122.20. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $145.00. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same quarter in the prior year, the company earned $3.73 EPS. The company’s revenue was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, sell-side analysts anticipate that Teleflex will post 6.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Teleflex

Hedge funds have recently made changes to their positions in the business. Empowered Funds LLC lifted its position in shares of Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares in the last quarter. Jane Street Group LLC grew its holdings in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after purchasing an additional 1,895 shares during the last quarter. American Century Companies Inc. raised its holdings in Teleflex by 32.7% in the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after acquiring an additional 3,360 shares during the period. Invesco Ltd. increased its stake in shares of Teleflex by 1.2% in the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after purchasing an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after buying an additional 521 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.